Compass Therapeutics, Inc.CMPXNASDAQ
LOADING
|||
Switch Symbol:
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
28.28%
↑ 215% above average
Average (29q)
-24.59%
Historical baseline
Range
High:89.29%
Low:-651.87%
Volatility
-3014.4%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 28.28% |
| Q2 2025 | -19.53% |
| Q1 2025 | -10.64% |
| Q4 2024 | -43.43% |
| Q3 2024 | 19.85% |
| Q2 2024 | -21.22% |
| Q1 2024 | 19.59% |
| Q4 2023 | -34.63% |
| Q3 2023 | 11.65% |
| Q2 2023 | -43.91% |
| Q1 2023 | 32.40% |
| Q4 2022 | 3.18% |
| Q3 2022 | -40.98% |
| Q2 2022 | -18.60% |
| Q1 2022 | 44.83% |
| Q4 2021 | -117.26% |
| Q3 2021 | 89.29% |
| Q2 2021 | -651.87% |
| Q1 2021 | 11.55% |
| Q4 2020 | 8.30% |
| Q3 2020 | -64.66% |
| Q2 2020 | 13.20% |
| Q1 2020 | 3.18% |
| Q4 2019 | 22.68% |
| Q3 2019 | 2.92% |
| Q2 2019 | 18.22% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |